Elli Malakounidou

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial

Τheodoros Karampitsakos, Panagiota Tsiri, Matthaios Katsaras et al. · Clinical Microbiology and Infection · 2022 · 42 citations · Full text

Open Label, Tocilizumab Versus Baricitinib, Clinical Infectious Disease +7

Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model

Τheodoros Karampitsakos, Vasilina Sotiropoulou, Matthaios Katsaras et al. · Frontiers in Medicine · 2023 · 21 citations · Full text

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

Τheodoros Karampitsakos, Elli Malakounidou, Vasilina Dimakopoulou et al. · Respiratory Research · 2021 · 17 citations · Full text

Clinical features and outcomes of patients with myositis associated-interstitial lung disease

Τheodoros Karampitsakos, Vasilios Tzilas, Serafeim Chrysikos et al. · Frontiers in Medicine · 2023 · 17 citations · Full text

Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model

Τheodoros Karampitsakos, Christina Kalogeropoulou, Vasilios Tzilas et al. · Respiration · 2021 · 12 citations